Hepatic encephalopathy - Therapy;Hepatische Enzephalopathie - Therapie

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 50, 2003, Pages 2658-2660

  Wettstein, M ^a   Haussinger D ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMMONIA; ANTIBIOTIC AGENT; DIURETIC AGENT; FLUMAZENIL; LACTITOL; LACTULOSE; NEOMYCIN; ORNITHINE ASPARTATE; PAROMOMYCIN; RIFAXIMIN; SEDATIVE AGENT; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; DRUG INDICATION; HEPATIC ENCEPHALOPATHY; HUMAN; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; PATIENT CARE; PROTEIN METABOLISM; PROTEIN RESTRICTION; STANDARD; TREATMENT INDICATION;

ADMINISTRATION, ORAL; AMMONIA; ANTI-BACTERIAL AGENTS; DIET, PROTEIN-RESTRICTED; DIPEPTIDES; FLUMAZENIL; GABA MODULATORS; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER DISEASES;

EID: 0346249823     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-45477     Document Type: Article

References (17)

1. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double-blind controlled trial. Gastroenterology 1977; 72: 573-578
2. Häussinger D, Steeb R, Gerok W. Metabolic alkalosis as driving force for urea synthesis in liver disease: pathogenic model and therapeutic implications. Clin Invest 1992; 70: 411-415
3. Heemann U, Treichel U, Loock J, Philipp T et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002; 36: 949-958
4. Horst D, Grace ND, Conn HO, Schiff E et al. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology 1984; 4: 279-287
5. Huber M, Rössle M, Siegerstetter V, Ochs A et al. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Hepatogastroenterology 2001; 48: 541-544
6. Kircheis G, Nilius R, Berndt H, Buchner M et al. Therapeutic efficacy of L-ornithine-L-aspartate infusion concentrate in patients with liver cirrhosis and hepatic encephalopathy: A placebo-controlled double-blind study. Hepatology 1997; 25: 1351-1360
7. Kircheis G, Wettstein M, vom Dahl S, Häussinger D. Clinical efficacy of L-ornithine-L-asparate in the management of hepatic encephalopathy. Metabolic Brain Disease 2002; 17: 453-462
8. Laccetti M, Manes G, Uomo G, Lionello M et al. Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study. Dig Liv Dis 2000; 32: 335-338
9. Marchesini G, Dioguardi FS, Bianchi GP et al. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial J Hepatol 1990; 11: 1-10
10. Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology 1996; 23: 1084-1092
11. Mas A, Rodés J, Sunyer L, Rodrigo L et al. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled trial. J Hepatol 2003; 38: 51-58
12. Morgan MY, Hawley KE. A randomized double-blind trial of lactitol and lactulose in acute hepatic encephalopathy in cirrhotic patients. Hepatology 1987; 7: 1278-1284
13. Naylor CD, O'Rourke K, Detoky AJ, Baker JP. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy: A meta-analysis. Gastroenterology 1989; 97: 1033-1042
14. Stauch S, Kircheis G, Adler G, Beckh K et al. L-ornithine-L-aspartate granulate in the treatment of latent and mild chronic hepatic encephalopathy (HE): A placebo-controlled double-blind study. Journal of Hepatology 1998; 28: 856-864
15. Uribe M, Campollo O, Vargas F, Ravelli GP et al. Acidifying enemas (lactitol and lactose) versus nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind randomized clinical trial. Hepatology 1987; 7: 639-643
16. Tromm A, Griga T, Graving I, Hilden H et al. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial. Hepatogastroenterology 2000; 47: 473-477
17. Schepke M, Reichel C, Ziske C, Spengler U, Caselmann WH, Sauerbruch T. Leberzirrhose - Komplikationen und Therapie. Dtsch Med Wochenschr 2001; 36: 975-984